Related references
Note: Only part of the references are listed.Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy
Martin Potter et al.
AIDS (2010)
Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study
Marina B. Klein et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus
Juan Berenguer et al.
HEPATOLOGY (2009)
Initiation of antiretroviral therapy at CD4 cell counts >= 350 cells/mm(3) does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency
Kenneth A. Lichtenstein et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression
Peter Bacchetti et al.
BMC INFECTIOUS DISEASES (2007)
Liver biopsy assessment in chronic hepatitis
Jay H. Lefkowitch
ARCHIVES OF MEDICAL RESEARCH (2007)
The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients
Barbara H. McGovern et al.
CLINICAL INFECTIOUS DISEASES (2007)
CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL
D. M. Moore et al.
HIV MEDICINE (2006)
Immunologic response to antiretroviral therapy in hepatitis C virus - Coinfected adults in a population-based HIV/AIDS treatment program
P Braitstein et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients
H Al-Mohri et al.
HIV MEDICINE (2005)
CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3
T Hulgan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: A meta-analysis
MF Miller et al.
CLINICAL INFECTIOUS DISEASES (2005)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
Estimation of CD4 T-lymphocyte counts from percent CD4 T-lymphocyte determinations in HIV-1-infected subjects in sub-Saharan Africa
E Sandström et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2003)
Hepatitis C and progression of HIV disease
MS Sulkowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
MS Sulkowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
